Robert L. Hymers III resigned as independent director at Electromedical Technologies, Inc.
“On July 1, 2023, Robert L. Hymers, III resigned as an independent director of the Company.”
Electromedical Technologies, Inc — fact timeline
Source-grounded facts extracted from Electromedical Technologies, Inc's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Electromedical Technologies, Inc completed a disposition involving Care National Healthcare Services, Inc. for $2,000,000.00 (closed 2023-03-15).
“On March 15, 2023, the Registrant and Care National Healthcare Services, Inc. ("Care National") closed a material definitive agreement. Pursuant to the terms of the agreement, the Registrant sold its real property located at 16561 N. 92nd Street, Ste. 101, Scottsdale, AZ 85260, to Care National in exchange for a purchase price of $2,000,000.00, with net proceeds to the Registrant of $1,358,710.56.”
Electromedical Technologies, Inc entered into a asset purchase with Care National Healthcare Services, Inc. valued at $2,000,000.00 (effective 2023-03-15).
“On March 15, 2023, the Registrant and Care National Healthcare Services, Inc. ("Care National") closed a material definitive agreement. Pursuant to the terms of the agreement, the Registrant sold its real property located at 16561 N. 92nd Street, Ste. 101, Scottsdale, AZ 85260, to Care National in exchange for a purchase price of $2,000,000.00, with net proceeds to the Registrant of $1,358,710.56.”
Electromedical Technologies, Inc: Increased authorized shares to two billion and one, including Common Stock, Series A Preferred, and Series B Preferred; par value $0.00001 per share (effective 2023-01-31).
“On January 31, 2023, the board of directors approved a resolution to amend the Company’s Certificate of Incorporation to: (1) increase the Company’s authorized shares to two billion and one shares of capital stock, including: one hundred and ninety-nine million shares designated as “Common Stock,” with a par value of $0.00001 per share; one million shares designated as “Series A Preferred Shares,” par value $0.00001 per share; and one share designated as “Series B Preferred Shares,” par value $0.00001 per share.”
Electromedical Technologies, Inc underwent a change of control involving Matthew Wolfson (closed 2023-01-26).
“Matthew Wolfson entered into an executive employment agreement. The Company agreed, as partial consideration”
Robert L. Hymers III was appointed as Independent Director at Electromedical Technologies, Inc.
“On February 1, 2023, effective January 1, 2023, the Company appointed Robert L. Hymers, III, age 39, as an independent director and member of the compensation committee of the Company for a term of six months.”
Robert L. Hymers, III was appointed as Director at Electromedical Technologies, Inc.
“On December 20, 2022, the Company appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.”
Petar Gajic was appointed as Director at Electromedical Technologies, Inc.
“On December 20, 2022, the Company appointed Petar Gajic and Robert L. Hymers, III to the board of directors by written consent of the shareholder beneficially owning 60.04% of the votes eligible to be cast according to Sections 2.11 and 2.12(b) of the Company's By-Laws.”
Lee Benson resigned as independent director at Electromedical Technologies, Inc.
“On December 12, 2022, Lee Benson resigned as an independent director of the Company.”
Lee Benson was appointed as independent director at Electromedical Technologies, Inc.
“On June 7, 2022, the registrant appointed Lee Benson, age 61, as an independent director of the Company.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.